Annual SGA
$2.23 M
-$67.20 K-2.93%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual SGA is $2.23 million, with the most recent change of -$67.20 thousand (-2.93%) on December 1, 2023.
- During the last 3 years, XRTX annual SGA has risen by +$1.60 million (+256.72%).
- XRTX annual SGA is now -2.93% below its all-time high of $2.29 million, reached on December 31, 2022.
Performance
XRTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$546.60 K
-$271.30 K-33.17%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly SGA is $546.60 thousand, with the most recent change of -$271.30 thousand (-33.17%) on September 1, 2024.
- Over the past year, XRTX quarterly SGA has increased by +$61.80 thousand (+12.75%).
- XRTX quarterly SGA is now -33.17% below its all-time high of $817.90 thousand, reached on June 1, 2024.
Performance
XRTX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$80.72 M
-$736.70 K-0.92%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM SGA is -$80.72 million, with the most recent change of -$736.70 thousand (-0.92%) on September 1, 2024.
- Over the past year, XRTX TTM SGA has dropped by -$82.95 million (-3723.62%).
- XRTX TTM SGA is now -24317.21% below its all-time high of -$330.60 thousand.
Performance
XRTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
XRTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.9% | +12.8% | -3723.6% |
| 3 y3 years | +256.7% | +7.1% | -3720.2% |
| 5 y5 years | +350.4% | +7.1% | -3720.2% |
XRTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | +40.6% | -33.2% | +13.3% | -105.9% | at low |
| 5 y | 5-year | -2.9% | +640.8% | -33.2% | +607.5% | -308.8% | at low |
| alltime | all time | -2.9% | +7451.5% | -33.2% | +607.5% | <-9999.0% | at low |
XORTX Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $546.60 K(-33.2%) | $2.36 M(+1.6%) |
| Jun 2024 | - | $817.90 K(+59.7%) | $2.32 M(+4.3%) |
| Mar 2024 | - | $512.10 K(+5.6%) | $2.23 M(+0.1%) |
| Dec 2023 | $2.23 M(-2.9%) | $484.80 K(-5.0%) | $2.23 M(-1.1%) |
| Sep 2023 | - | $510.10 K(-29.4%) | $2.25 M(+1.2%) |
| Jun 2023 | - | $722.30 K(+41.5%) | $2.22 M(-0.2%) |
| Mar 2023 | - | $510.50 K(+0.2%) | $2.23 M(-7.0%) |
| Dec 2022 | $2.29 M(+44.8%) | $509.60 K(+5.6%) | $2.40 M(-8.4%) |
| Sep 2022 | - | $482.40 K(-33.7%) | $2.62 M(+29.1%) |
| Jun 2022 | - | $727.30 K(+7.0%) | $2.03 M(+7.0%) |
| Mar 2022 | - | $679.60 K(-6.8%) | $1.90 M(+15.8%) |
| Dec 2021 | $1.58 M(+153.8%) | - | - |
| Dec 2021 | - | $729.50 K(-777.3%) | $1.64 M(+50.4%) |
| Sep 2021 | - | -$107.70 K(-118.1%) | $1.09 M(-18.8%) |
| Jun 2021 | - | $594.80 K(+41.4%) | $1.34 M(+38.9%) |
| Mar 2021 | - | $420.60 K(+132.4%) | $964.90 K(+56.7%) |
| Dec 2020 | $624.50 K(+107.7%) | $181.00 K(+25.5%) | $615.80 K(+15.8%) |
| Sep 2020 | - | $144.20 K(-34.2%) | $531.70 K(+14.6%) |
| Jun 2020 | - | $219.10 K(+206.4%) | $463.80 K(+46.3%) |
| Mar 2020 | - | $71.50 K(-26.2%) | $317.00 K(-1.4%) |
| Dec 2019 | $300.70 K | $96.90 K(+27.0%) | $321.50 K(+20.5%) |
| Sep 2019 | - | $76.30 K(+5.5%) | $266.80 K(-0.9%) |
| Jun 2019 | - | $72.30 K(-4.9%) | $269.30 K(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $76.00 K(+80.1%) | $296.10 K(-39.9%) |
| Dec 2018 | $494.60 K(+81.2%) | $42.20 K(-46.4%) | $493.00 K(-15.9%) |
| Sep 2018 | - | $78.80 K(-20.5%) | $585.90 K(-6.8%) |
| Jun 2018 | - | $99.10 K(-63.7%) | $628.60 K(+11.3%) |
| Mar 2018 | - | $272.90 K(+161.9%) | $564.70 K(+52.1%) |
| Dec 2017 | $272.90 K(+86.0%) | $104.20 K(+237.2%) | $371.30 K(+39.0%) |
| Nov 2017 | - | $30.90 K(-54.4%) | $267.10 K(-4.3%) |
| Sep 2017 | - | $67.80 K(+26.3%) | $279.00 K(+32.1%) |
| Aug 2017 | - | $53.70 K(+52.6%) | $211.20 K(+7.0%) |
| May 2017 | - | $35.20 K(-25.4%) | $197.30 K(+0.7%) |
| Mar 2017 | - | $47.20 K(+46.1%) | $196.00 K(+31.7%) |
| Feb 2017 | $146.70 K(-49.3%) | $32.30 K(-24.5%) | $148.80 K(+42.7%) |
| Dec 2016 | $289.60 K(+91.8%) | - | - |
| Nov 2016 | - | $42.80 K(+7.5%) | $104.30 K(-27.1%) |
| Aug 2016 | - | $39.80 K(+17.4%) | $143.10 K(+3.3%) |
| May 2016 | - | $33.90 K(-377.9%) | $138.50 K(-10.6%) |
| Feb 2016 | $151.00 K(+411.9%) | -$12.20 K(-115.0%) | $155.00 K(-13.7%) |
| Nov 2015 | - | $81.60 K(+131.8%) | $179.70 K(+73.3%) |
| Aug 2015 | - | $35.20 K(-30.2%) | $103.70 K(+39.0%) |
| May 2015 | - | $50.40 K(+303.2%) | $74.60 K(+147.8%) |
| Feb 2015 | $29.50 K | $12.50 K(+123.2%) | $30.10 K(+71.0%) |
| Nov 2014 | - | $5600.00(-8.2%) | $17.60 K(+46.7%) |
| Aug 2014 | - | $6100.00(+3.4%) | $12.00 K(+103.4%) |
| May 2014 | - | $5900.00 | $5900.00 |
FAQ
- What is XORTX Therapeutics annual SGA?
- What is the all time high annual SGA for XORTX Therapeutics?
- What is XORTX Therapeutics annual SGA year-on-year change?
- What is XORTX Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly SGA year-on-year change?
- What is XORTX Therapeutics TTM SGA?
- What is the all time high TTM SGA for XORTX Therapeutics?
- What is XORTX Therapeutics TTM SGA year-on-year change?
What is XORTX Therapeutics annual SGA?
The current annual SGA of XRTX is $2.23 M
What is the all time high annual SGA for XORTX Therapeutics?
XORTX Therapeutics all-time high annual SGA is $2.29 M
What is XORTX Therapeutics annual SGA year-on-year change?
Over the past year, XRTX annual SGA has changed by -$67.20 K (-2.93%)
What is XORTX Therapeutics quarterly SGA?
The current quarterly SGA of XRTX is $546.60 K
What is the all time high quarterly SGA for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly SGA is $817.90 K
What is XORTX Therapeutics quarterly SGA year-on-year change?
Over the past year, XRTX quarterly SGA has changed by +$61.80 K (+12.75%)
What is XORTX Therapeutics TTM SGA?
The current TTM SGA of XRTX is -$80.72 M
What is the all time high TTM SGA for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM SGA is -$330.60 K
What is XORTX Therapeutics TTM SGA year-on-year change?
Over the past year, XRTX TTM SGA has changed by -$82.95 M (-3723.62%)